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Three-dimensional US
Assessment of Hepatic
Volume, Head Circumference,
and Abdominal Circumference
in Healthy and Growth-
restricted Fetuses1
PURPOSE: To establish reproducibility and normal values for fetal hepatic volume
and its significance in identification of fetal growth restriction relative to head and
upper abdominal circumferences according to a cross-sectional study design.
MATERIALS AND METHODS: Pregnant women (n  135) underwent ultrasonog-
raphy. The coefficient of variation (CV) for hepatic volume scans obtained at 0 and
20 minutes and hepatic area tracings, performed twice for each scan, was deter-
mined (n 20; range, 23–36 weeks). Normal data for hepatic volume and head and
upper abdominal circumferences were obtained (n  85; range, 20–36 weeks) and
related to data from growth-restricted fetuses (birth weight  P5 centile; n  24;
range, 22–36 weeks).
RESULTS: CV was 2.9% for volume scans and 1.6% for area tracings. In 85
uncomplicated cases, mean fetal hepatic volume (P50 centile) was 9.7 mL  4.4
(SD) at 20 weeks and 96.4 mL  8.2 at 36 weeks of gestation. In 24 growth-
restricted fetuses, hepatic volume, head circumference, and upper abdominal cir-
cumference expressed as percentages of the normal P50 centile were 45%, 90%,
and 82%, respectively. Mean difference in hepatic volume between fetal growth
restriction and normal fetal development, as expressed with the z score, 4.32 
1.4, was significantly different (P  .05) from that for head circumference, 3.04 
1.3, but not from that for upper abdominal circumference, 4.7  1.2. Fetal
hepatic measurement was obtained in 109 pregnancies.
CONCLUSION: Acceptable reproducibility exists for hepatic volume determina-
tions. In fetal growth restriction, reduction is more pronounced for hepatic volume
than for head or upper abdominal circumference; hepatic volume is a better
discriminator than head circumference but not upper abdominal circumference.
© RSNA, 2002
Measurement of fetal upper abdominal circumference is considered the mainstay of
ultrasonographic (US) determination of fetal growth and estimation of fetal weight (1,2).
The fetal liver makes up most of the abdomen, as measured by means of abdominal
circumference. Measurement of fetal hepatic volume to identify fetal growth restriction is
of interest, since both the human and the rat have severely depleted hepatic glycogen
stores associated with growth restriction (3). Due to fetal malnutrition, reduction in fetal
hepatic weight is more pronounced than is reduction in brain weight because of the
brain-sparing effect, which reflects redistribution of fetal blood flow during chronic fetal
hypoxemia (4). Measurement of fetal hepatic volume may thus contribute to the early
detection of fetal growth restriction. Authors of another study (5) dealing with measure-
ments of fetal hepatic length in fetal growth restriction suggest that other intraabdominal
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organs, reduced amounts of fat, or eleva-
tion of the diaphragm because of poor
pulmonary growth also contribute to re-
duced fetal upper abdominal circumfer-
ence.
Recently, a more direct approach to
measurement of fetal hepatic volume by
using three-dimensional (3D) US was re-
ported (6), including preliminary data on
normal fetal hepatic volume from our
center (Erasmus University Medical Cen-
tre, University Hospital Rotterdam-Dijk-
zigt, Rotterdam, the Netherlands) (7). To
our knowledge, no data are available
about 3D US measurement of fetal he-
patic volume in fetal growth restriction.
Therefore, the purpose of our study was
to establish reproducibility and normal
values for fetal hepatic volume and its
importance in identification of fetal
growth restriction relative to head and
upper abdominal circumferences accord-
ing to a cross-sectional study design.
MATERIALS AND METHODS
During the period of April 1997 to Octo-
ber 2000, 135 women with a singleton
pregnancy from our outpatient unit
(Erasmus University Medical Centre,
University Hospital Rotterdam-Dijkzigt,
Rotterdam, the Netherlands) consented
to participate in the study after approval
was granted by the institutional ethics
review board. This group included 34
normal singleton pregnancies from a pre-
vious study (7).
Technically acceptable US hepatic re-
cordings were obtained in 85 of 104 un-
complicated pregnancies and in 24 of 31
pregnancies associated with fetal growth
restriction, which resulted in success
rates of 82% and 77%, respectively. A US
hepatic recording qualified as acceptable
if the entire contour of the liver could be
manually outlined. Recording failures
were mainly due to maternal obesity, fe-
tal position, or excessive fetal movement.
A hepatic volume calculation took ap-
proximately 15 minutes. Each woman
underwent evaluation only once in the
study.
An uncomplicated pregnancy consti-
tuted the delivery of a healthy neonate
with a birth weight between the 5th and
95th centile for weight of gestation, ac-
cording to the Kloosterman tables (8). Fe-
tal growth restriction was represented by
fetal upper abdominal circumference be-
low the 5th centile (9), and a birth weight
below the 5th centile for weight of gesta-
tion was confirmed after delivery, accord-
ing to the Kloosterman tables (8).
Pregnancy duration was determined
from last menstruation and confirmed by
means of US before 20 weeks of gestation.
Gestation was at 20–36 weeks (median,
30 weeks) in uncomplicated pregnancies
and 22–36 weeks (median, 29 weeks) in
the subset of pregnancies with fetal
growth restriction. Maternal age in all
109 pregnancies was 19–42 years (me-
dian, 29 years).
The 5-MHz annular array transducer
(VSW 3–5; Kretz Technik, Zipf, Austria) of
the US machine (Combison 530-D; Kretz
Technik) was used for volume scanning.
Two examiners (S.M.E.B. and J.A.M.L.)
obtained the data and hepatic volume
measurements.
Organ volumes were determined by
slicing through collected images and re-
cording a truncated pyramidal volume.
Depth, longitudinal, and transverse di-
mensions of this volume were adjustable,
with an initial area of 6.6  3.3 cm, up to
a maximum area of 28  22 cm at a
depth of 20 cm. These dimensions pro-
vide a maximum scanned volume of 5.9
L. The maximum resolution in the longi-
tudinal direction was 512 ultrasound
lines for each of the maximum of 500
sections in the transverse, or sweep, di-
rection.
In the present study, the opening angle
of each plane was 70°, and the angle of
the volume sample was limited to a max-
imum of 60°. The depth of the volume
was restricted to 12–16 cm, with a reso-
lution of 210 sections per volume. After
each US scan, the volume was presented
in three perpendicular planes on the
monitor and represented frontal, sagittal,
and transverse cross sections of the fetus.
Data were stored on hard disk (Iomega
Jaz Drive; Iomega, Roy, Utah) for off-line
analysis.
In a first step toward fetal hepatic vol-
ume determination, a frontal cross sec-
tion of the liver anterior to the stomach
was visualized. In a simultaneously dem-
onstrated sagittal cross section, the out-
line of the liver was traced manually in
approximately 10 sagittal sections be-
tween the most lateral left and right
points of the diaphragm in the frontal
plane. The liver was measured from its
upper limit at the diaphragm to its lower
limit at the distal rim. The system auto-
matically kept track of the distances be-
tween the sections and calculated the to-
tal volume after each area measurement
was completed.
In each instance, fetal hepatic volume
recording was followed by measurement
of fetal head and upper abdominal cir-
cumferences and femur length. Fetal
weight was estimated from these biomet-
ric parameters by using the Hadlock for-
mula (10).
Reproducibility
The first 20 uncomplicated singleton
pregnancies examined by S.M.E.B. were
enrolled in the reproducibility study.
Pregnancy duration was at 23–36 weeks
of gestation. Hepatic volume recordings
were obtained at 0 and 20 minutes to
determine the intraobserver variability as
expressed by means of the coefficient of
variation (CV). To establish the CV for
fetal hepatic volume tracings, the trac-
ings were performed twice for each he-
patic volume recording—the one ob-
tained at 0 minutes and the one obtained
at 20 minutes. Analysis of variance was
used to calculate the variance and the SD
within the separate categories of record-
ings and tracings. The CV was calculated
by dividing the SD by the overall mean of
the measurements.
Statistics
The gestational age–related reference
centiles—P5, P50, and P95—were con-
structed by using the method described
by Altman (11). According to this proce-
dure, we modeled the relationships
among hepatic volume, head circumfer-
ence, upper abdominal circumference,
and gestational age by means of a cubic
polynomial. Either the linear or qua-
dratic term was left out because of too
low a tolerance (SPSS version 8.0 for Win-
dows; SPSS, Chicago, Ill). The age-specific
SD was obtained from linear regression of
the absolute residuals on gestational age.
Polynomial linear regression was used to
calculate the relationship between he-
patic volume and estimated fetal weight.
Data from hepatic volume, head cir-
cumference, and upper abdominal cir-
cumference for fetal growth restriction
were expressed as ratios. Every observed
value of the growth-restricted fetus was
divided by the corresponding normal
P50 value for gestational age. Abdominal
circumference and head circumference
ratios were raised to the power of three to
estimate the abdominal and head vol-
ume reduction in growth-restricted fe-
tuses. These values were compared with
the 3D hepatic volume data for fetal
growth restriction.
Mean difference in hepatic volume be-
tween fetuses with growth restriction and
those with normal development was de-
termined with the z score, which was cal-
culated as follows: z score  hepatic vol-
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umeFGR  P50normal/SDnormal, where FGR
represents fetuses with growth restriction
and “normal” represents fetuses with
normal development. In the group with
fetal growth restriction, the percentage of
normal P50 values and z scores of the
hepatic volume were compared with up-
per abdominal and head circumference
values by means of the paired sample t
test. The level of statistical significance
was set at .05.
RESULTS
The number of confirmed normally de-
veloped fetuses was 85 and the number
of growth-restricted fetuses was 24. CVs
for hepatic volume recordings and he-
patic volume tracings were 2.9% (1.735/
59.791) and 1.6% (0.968/59.791), respec-
tively, which resulted in a total CV of
3.3% (1.986/59.791) for all fetuses. The
number of uncomplicated pregnancies
per gestational week varied between
three and 12. Mean gestational age at
delivery was 40.1 weeks  1.2 (SD). In
uncomplicated pregnancies, mean fetal
hepatic volume was 9.7 mL  4.4 at 20
weeks and 96.4 mL  8.2 at 36 weeks of
gestation (Fig 1). At 20 and 36 weeks,
respectively, mean fetal head circumfer-
ences (Fig 2) were 17.5 cm 0.7 and 31.7
cm  0.9, and mean fetal upper abdom-
inal circumferences (Fig 3) were 14.8
cm  0.8 and 31.4 cm  1.0 in uncom-
plicated pregnancies. A significant linear
relation was established between fetal he-
patic volume and estimated fetal weight
(P  .001) (Fig 4).
In fetuses with growth restriction,
mean gestational age at delivery was 31
weeks  4.6, mean fetal birth weight was
1,140 g  636, and mean lag time be-
tween hepatic volume measurement and
delivery was 2.5 weeks  1.4. Fetal he-
patic volume, fetal head circumference,
and upper abdominal circumference
were below the 5th centile of the refer-
ence chart in most or all cases (Figs 1–3).
Mean difference in hepatic volume be-
tween fetuses with growth restriction and
those with normal development as ex-
pressed by means of percentage of the
normal P50 values was 45%  13.0,
which is significantly different (P  .001)
from head circumference, 90%  4.2,
and fetal upper abdominal circumfer-
ence, 82%  4.1. Within the subset of
growth-restricted fetuses, mean hepatic
volume was also significantly smaller
(P  .001) than the estimated head vol-
ume of 75%  11 and estimated abdom-
inal volume of 56%  8.4. Mean differ-
ence in hepatic volume between fetuses
with growth restriction and those with
normal development, as expressed with
the z score, was 4.32  1.4, which is
significantly different (P  .05) from the
z score for head circumference, 3.04 
1.3, but not that for fetal upper abdomi-
nal circumference, 4.7  1.2.
DISCUSSION
The present study focused on 3D US mea-
surements of fetal hepatic volume in nor-
mal and abnormal fetal development
during the second half of pregnancy. The
success rate in acquiring technically ac-
ceptable fetal hepatic volume measure-
ments was as high as 82% in uncompli-
cated pregnancies and lower (77%) in
fetuses with growth restriction.
Low image quality occurred in the
presence of maternal obesity or when the
fetal back was in the anterior position. In
the latter case, fetal bones, particularly
vertebrae and ribs, caused shadows on
some parts of the fetal abdomen, which
limited the definition of some sections
inside the volume box. Reduced amniotic
fluid volume constituted a reason for not
obtaining a technically acceptable he-
patic volume measurement in the growth-
restricted fetus. In the present study, the
second half of pregnancy was not selected
because of 3D hepatic volume measure-
ment limitation before 20 weeks of gesta-
Figure 1. Graph shows hepatic volume in milliliters relative to
gestational age in weeks. All hepatic volumes of the growth-restricted
fetuses are below the P5 reference level. Note that these hepatic
volume data are even more reduced relative to the P50 reference level
than are the abdominal circumference data (Fig 3). However, the
mean difference in hepatic volume between fetal growth restriction
and normal fetal development (z score) is not significantly different
from that for fetal upper abdominal circumference. o  individual
normal values, ●  individual fetal growth-restricted values. Solid
lines represent the P5, P50, and P95 reference lines. For P50, cubic
fit 0.0012GA3 0.0443GA2 18.268, where GA is gestational
age. P5  P95  P50  1.64 (SD) (0.2408  GA 0.4560).
Figure 2. Graph shows head circumference in centimeters relative
to gestational age in weeks. The head circumference data in the
growth-restricted fetuses are less reduced relative to the P50 reference
level than are hepatic volume and upper abdominal circumference
data. However, the mean difference in hepatic volume between fetal
growth restriction and normal fetal development (z score) is signifi-
cantly (P  .05) different from that for fetal head circumference. o 
individual normal values, ●  individual fetal growth-restricted val-
ues. Solid lines represent the P5, P50, and P95 reference lines. For P50,
cubic fit  0.000274  GA3  1.564502  GA  11.801200, where
GA is gestational age. P5  P95  P50  1.64 (0.016072  GA 
0.343292).
Volume 223  Number 3 Three-dimensional US Assessment in Fetuses  663
tion (6) but because fetal growth restriction
usually does not begin until 22–24 weeks
of gestation.
Acceptable reproducibility of hepatic
volume measurements is essential before
embarking on a clinical study. We dem-
onstrated that the reproducibility of fetal
hepatic volume recordings and tracings is
good, with a total CV less than 4%. We
did not study the accuracy of fetal he-
patic volume measurements with 3D US,
but other investigations (12–14) have
been performed to confirm the accuracy
of 3D US volume measurements.
In uncomplicated pregnancies, fetal
hepatic volume demonstrates a tenfold
increase with advancing gestational age
and increasing fetal weight. The regres-
sion line, shown in Figure 4, demon-
strates that the hepatic volume is propor-
tional to estimated fetal weight during
the second half of pregnancy.
Currently, US measurement of fetal
head and upper abdominal circumferences
is the most widely used method of estab-
lishing impaired fetal growth (15,16). The
detection of fetal growth restriction by
means of head circumference measure-
ments may be limited because of fetal
brain sparing in the presence of chronic
fetal hypoxemia. Results of a majority of
studies (15,16) have shown that the most
effective method of detecting fetal growth
restriction is measurement of the upper ab-
dominal circumference. However, this
measurement is not satisfactory because
the positive predictive value for detecting
fetal growth restriction may be as low as
21% (17). Therefore, accurate assessment
of hepatic volume may contribute to the
early detection of growth-restricted fetuses,
since hepatic weight in these fetuses is re-
duced due to reduction in hepatic glyco-
gen stores (3).
Fetal hepatic volume has been esti-
mated indirectly through measurement
of hepatic length, circumference, and area
by using two-dimensional US (18,19) and
more recently by using 3D US. A linear
relationship has been described between
two-dimensional fetal hepatic length and
fetal upper abdominal circumference in
uncomplicated pregnancies (18,19). Three-
dimensional US measurements of the
normal hepatic volume demonstrated a
close linear relation between hepatic vol-
ume and estimated fetal weight (6,7).
Baker et al (17) were able to show that
fetal hepatic volume measurements ob-
tained with magnetic resonance (MR) im-
aging allowed accurate detection of fe-
tuses that were subsequently found to be
growth restricted. However, MR imaging
is associated with reduced patient accept-
ability and high cost.
The present study results show that fe-
tal growth restriction is associated with
reduced hepatic volume in every in-
stance. Moreover, when expressed as a
percentage of the normal P50, the de-
crease in hepatic volume is more pro-
nounced than is the reduction in head
circumference or upper abdominal cir-
cumference. When looking at the mean
difference in hepatic volume between
normal and reduced fetal growth, as ex-
pressed with the z score, we found a sig-
nificant difference only when comparing
these values with head circumference,
which confirms the brain-sparing effect
during abnormal fetal development.
Three-dimensional US measurements
of fetal hepatic volume show good repro-
ducibility. Normal fetal hepatic volume
is tenfold larger at the end of gestation, as
compared with that at the beginning of
the second half of pregnancy. Fetal
growth restriction affects fetal size, but
fetal hepatic volume measurement is not
a better discriminator for growth restric-
tion than is upper abdominal circumfer-
ence measurement.
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